Circulating Biomarkers for Glioma
Enrolling By Invitation
18-99 years
All
Phase
N/A
50 participants needed
1 Location
Brief description of study
Subjects will be recruited from the Radiation Oncology and Neurosurgery practices at the Hospital of the University of Pennsylvania. The treating radiation oncologist will determine if the patient is a potential research candidate and has the capacity to consent.
The goal of this study is to collect and analyze blood samples from glioma cancer patients undergoing radiation therapy to determine the reliability of a circulating tumor cell assay. We will also be looking at the genetic mutations of the circulating glioma cells and comparing them to available tumor pathology.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: glioma,glioblastoma
-
Age: Between 18 Years - 99 Years
-
Gender: All
Updated on
01 Aug 2024.
Study ID: 843168
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com
